J. Langley

M. Mulvey, J. Langley, D. Stinson, 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002

J. Langley, L. Dodds, D. Fell, 2010, BMC infectious diseases.

Hospitalization Attributable to Influenza and Other Viral Respiratory Illnesses in Canadian Children

D. Schanzer, J. Langley, T. Tam, 2006, The Pediatric infectious disease journal.

An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.

J. Langley, N. MacDonald, S. Mcneil, 2011, Canadian journal of public health = Revue canadienne de sante publique.

Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016

J. Langley, J. Conly, J. Comeau, 2020, Antimicrobial Resistance & Infection Control.

Human challenge studies: a review of adequacy of reporting methods and results.

J. Langley, S. Halperin, Jennifer Kalil, 2012, Future microbiology.

Interobserver variability of croup scoring in clinical practice.

J. Langley, A. Chan, J. Leblanc, 2001, Paediatrics & child health.

Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization.

J. Langley, S. Desai, B. Warshawsky, 2010, Vaccine.

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada

J. Langley, S. Halperin, J. Bettinger, 2020, Emerging infectious diseases.

Sources of viral respiratory infections in Canadian acute care hospital healthcare personnel

M. Loeb, J. Langley, J. Raboud, 2020, Journal of Hospital Infection.

A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.

F. Aoki, J. Langley, K. Papp, 2011, Vaccine.

Influenza vaccine for all?

J. Langley, J. Feightner, 2005, Canadian Medical Association Journal.

Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children

O. Vanderkooi, J. Langley, S. Halperin, 2011, The Pediatric infectious disease journal.

Potential resurgence of respiratory syncytial virus in Canada

J. Langley, A. Solimano, P. Lavoie, 2021, Canadian Medical Association Journal.

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein

J. Langley, D. Granoff, C. Quach, 2019, mSphere.

Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

J. Langley, S. Halperin, K. Top, 2020, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers

J. Langley, S. Halperin, J. Isenor, 2016, Human vaccines & immunotherapeutics.

A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

J. Langley, K. Lanctôt, B. Paes, 2011, Canadian respiratory journal.

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

J. Langley, S. Halperin, Laurence Fissette, 2016, The Journal of infectious diseases.

Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000.

E. Wang, J. Langley, J. Leblanc, 2003, The Journal of infectious diseases.

Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection control

B. Pourbohloul, J. Langley, L. Johnston, 2018, BMC Infectious Diseases.

A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

D. Vaughn, J. Langley, Ping Li, 2012, BMC Infectious Diseases.

Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.

J. Langley, S. Halperin, J. Graham, 2019, Vaccine.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

W. J. Ramsey, T. Monath, J. Alimonti, 2017, Canadian Medical Association Journal.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada

S. Trottier, M. Loeb, A. Chit, 2017, BMC Infectious Diseases.

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age

J. Langley, S. Halperin, S. Mcneil, 2013, Journal of the Pediatric Infectious Diseases Society.

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada

T. Delea, A. Chit, J. Langley, 2017, PloS one.

Incorporating economic evaluation into immunization decision making in Canada: a workshop

D. Fisman, A. Chit, J. Langley, 2014, Expert review of vaccines.

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

J. Langley, M. Reddish, S. Halperin, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Role of Clostridium difficile and Viruses as Causes of Nosocomial Diarrhea in Children

J. Langley, J. Leblanc, O. Goloubeva, 2002, Infection Control & Hospital Epidemiology.

Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers.

J. Langley, S. Halperin, F. Diaz-Mitoma, 2006, Vaccine.

Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children

J. Langley, S. Halperin, D. Radley, 2005, Human vaccines.

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

J. Langley, S. Halperin, D. Macdougall, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CARIFS: The Canadian Acute Respiratory Illness and Flu Scale

E. Wang, J. Langley, N. Young, 1999 .

Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.

J. Langley, S. Halperin, L. Fries, 2006, Vaccine.

Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study

S. Moghadas, M. Haworth-Brockman, J. Langley, 2022, BMC Public Health.

Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000.

D. Schanzer, J. Langley, T. Tam, 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.

J. Langley, T. Tam, 2004, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Sepsis in febrile neutropenic children with cancer

J. Langley, R. Gold, 1988, The Pediatric infectious disease journal.

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.

J. Langley, F. Noya, S. Halperin, 2007, Vaccine.

An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed com

J. Langley, S. Halperin, A. Tomovici, 2007, Vaccine.

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose.

J. Langley, F. Noya, M. Decker, 2012, Vaccine.

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose.

J. Langley, F. Noya, S. Halperin, 2011, Vaccine.

Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes.

A. Almudevar, D. Raoult, J. Langley, 2003, American journal of obstetrics and gynecology.

Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.

M. Mulvey, J. Langley, D. Gravel, 2015, Microbial drug resistance.

Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.

J. Langley, S. Halperin, S. Mcneil, 2019, Vaccine.

Unique epidemiology of nosocomial urinary tract infection in children.

J. Langley, J. Leblanc, M. Hanakowski, 2001, American journal of infection control.

Reducing infection transmission in the playroom: Balancing patient safety and family-centered care.

J. Langley, Mackenzie Grisdale, Chantal Leblanc, 2016, American journal of infection control.

Health Care Epidemiology Perspective on the October 2006 Recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis

J. Langley, W. Huskins, J. Siegel, 2007, Pediatrics.

Influenza update: NACI issues annual influenza prevention recommendations for the 2006/2007 season.

J. Langley, 2006, Paediatrics & child health.

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.

J. Langley, A. McGeer, J. Capellan, 2009, Vaccine.

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada

S. Moghadas, J. Langley, S. Halperin, 2021, EClinicalMedicine.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada

K. Wilson, S. Hawken, J. Langley, 2016, Human vaccines & immunotherapeutics.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

J. Langley, C. Sanford, Mitchell Zelman, 2015, Human vaccines & immunotherapeutics.

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

J. Langley, S. Halperin, M. Stanford, 2017, Human vaccines & immunotherapeutics.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

M. Taljaard, M. Mulvey, J. Langley, 2018, Canadian Medical Association Journal.

Estolate for the Treatment of Pertussis Azithromycin Is as Effective as and Better Tolerated Than Erythromycin

J. Langley, S. Halperin, F. Boucher, 2006 .

Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of aseptic meningitis

H. Davies, J. Strong, J. Langley, 2006, BMC infectious diseases.

From soap and water, to waterless agents: update on hand hygiene in health care settings.

J. Langley, 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Collaborative Network on Infections in Canada (PICNIC) RSV Database Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Does Ribavirin Impact on the Hospital Course of Children With Respiratory

E. Wang, J. Langley, N. MacDonald, 2013 .

Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.

E. Wang, J. Langley, N. MacDonald, 1997, Pediatrics.

Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]

J. Langley, J. Leblanc, P. Pianosi, 2005, BMC pediatrics.

A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults

J. Langley, M. Reddish, S. Halperin, 2006 .

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein

E. Walsh, A. Falsey, J. Langley, 2020, Human vaccines & immunotherapeutics.

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial

J. Langley, S. Halperin, D. Macdougall, 2016, Human vaccines & immunotherapeutics.

Healthcare-Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program, 2007-2011.

Mark A. Miller, M. Mulvey, J. Langley, 2015, Journal of the Pediatric Infectious Diseases Society.

Operationalizing integrated needs-based workforce planning at Nova Scotia Health in response to the COVID-19 pandemic

J. Langley, A. Mackenzie, G. Tomblin Murphy, 2022, Healthcare management forum.

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, Ly-Mee Yu, 2009, The Pediatric infectious disease journal.

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.

J. Langley, C. Gill, Ly-Mee Yu, 2012, Vaccine.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

S. Trottier, M. Loeb, A. Chit, 2018, Vaccine.

Empyema associated with community-acquired pneumonia: A Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study

J. Langley, J. Kellner, U. Allen, 2008, BMC infectious diseases.

Pneumonia in Pregnancy

J. Langley, 2002 .

Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.

J. Langley, N. Crowcroft, T. Cesuroğlu, 2020, Vaccine.

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

J. Langley, B. Schepens, X. Saelens, 2018, The Journal of infectious diseases.

Surveillance methods for central venous access device-associated infections in Canadian pediatric hospitals.

J. Langley, L. Laroche, M. Hanakowski, 1995, The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections.

Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.

J. Langley, S. Halperin, B. Eastwood, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials

J. Langley, E. McClymont, S. Halperin, 2022, Human vaccines & immunotherapeutics.

Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study

J. Langley, Elie Haddad, J. Rozmus, 2013, Journal of Clinical Immunology.

Respiratory Watch: Development of a provincial system for respiratory syncytial virus surveillance in Nova Scotia, 2005-2008.

J. Langley, S. Sarwal, A. Al-Assam, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis.

J. Drake, J. Langley, J. Leblanc, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States

B. Singer, L. Meyers, A. Galvani, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States

Seyed M. Moghadas, David Champredon, Alison P. Galvani, 2020, Canadian Medical Association Journal.

Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

T. Dingle, A. Bharat, L. Hoang, 2020, Antimicrobial Resistance & Infection Control.

Early-Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome

L. Kovacs, A. Synnes, R. Sauve, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characteristics and outcome of infants with candiduria in neonatal intensive care - a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study

L. Kovacs, A. Synnes, R. Sauve, 2009, BMC infectious diseases.

Sepsis in febrile neutropenic children with cancer

J. Langley, R. Gold, 1988, The Pediatric infectious disease journal.

Defining urinary tract infection in the critically ill child

J. Langley, 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

S. Madhi, S. Stoszek, J. Langley, 2022, The Journal of infectious diseases.

Trends in Clostridioides difficile infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemic

J. Langley, J. Comeau, Bonita E. Lee, 2022, Infection control and hospital epidemiology.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

J. Crump, J. Langley, A. Cheng, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Respiratory syncytial virus - associated intensive care unit admission in children in Southern China

J. Langley, Zhenjiang Bai, Zhongqin Guo, 2013, BMC Research Notes.

Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019

J. Langley, J. Comeau, Bonita E. Lee, 2022, Emerging infectious diseases.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

J. Crump, J. Langley, A. Cheng, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of vaccination on COVID-19 outbreaks in the United States

B. Singer, A. Galvani, S. Moghadas, 2020, medRxiv.

A global prescription for adult immunization: time is catching up with us.

P. van Damme, J. Langley, J. Michel, 2010, Vaccine.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

J. Langley, S. Halperin, B. Ward, 2013, Human vaccines & immunotherapeutics.

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.

J. Langley, S. Halperin, B. Ward, 2012, Vaccine.

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.

David E. Anderson, P. van Damme, J. Langley, 2021, The Lancet. Infectious diseases.

Projecting demand for critical care beds during COVID-19 outbreaks in Canada

Seyed M. Moghadas, Alison P. Galvani, Burton H. Singer, 2020, Canadian Medical Association Journal.

History of penicillin allergy and referral for skin testing: evaluation of a pediatric penicillin allergy testing program.

J. Langley, S. Halperin, R. Bortolussi, 2002, Clinical and investigative medicine. Medecine clinique et experimentale.

Parental willingness to enter a child in a controlled vaccine trial.

J. Langley, S. Halperin, E. Mills, 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study

R. Long, E. Haddad, J. Langley, 2013, Journal of Clinical Immunology.

Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada

A. Galvani, S. Moghadas, J. Langley, 2020, medRxiv.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

S. Trottier, M. Loeb, A. Chit, 2017, The Journal of infectious diseases.

Original Article: A composite epidemic curve for seasonal influenza in Canada with an international comparison

Cecile Viboud, Dena L. Schanzer, C. Viboud, 2010, Influenza and other respiratory viruses.

Risk Factors for Central Venous Catheter–Associated Bloodstream Infection in Pediatric Patients: A Cohort Study

J. Langley, S. Kirkland, S. Kuhle, 2016, Infection Control & Hospital Epidemiology.

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age

J. Langley, J. Cailhier, P. Savard, 2020, Vaccines.

Community-Acquired Pneumonia in Children: A Multidisciplinary Consensus Review

J. Langley, Nova Scotia, J. Kellner, 2003 .

Risk factors for surgical site infection following cesarean delivery: a retrospective cohort study.

J. Langley, C. Woolcott, F. Ketcheson, 2017, CMAJ open.

The place of quinolones in paediatric anti-infective therapy.

J. Langley, 2001, Paediatrics & child health.

Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy.

J. Langley, S. Halperin, S. Mcneil, 2008, Vaccine.

Determining proton pump inhibitor prescription dispensing patterns and adherence to STOPP criteria for Nova Scotia Seniors Pharmacare Program beneficiaries.

A. Levy, J. Langley, I. Sketris, 2019, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016

J. Langley, J. Conly, J. Comeau, 2020, Antimicrobial Resistance and Infection Control.

Reply to Weber, von Cube, Sommer, Wolkewitz: Necessity of a Competing Risk Approach in Risk Factor Analysis of Central-Line–Associated Bloodstream Infection

J. Langley, S. Kirkland, S. Kuhle, 2017, Infection Control & Hospital Epidemiology.

Risk factors for mechanical complications of peripherally inserted central catheters in children

David J Greencorn, J. Langley, S. Kuhle, 2022, Infection Control & Hospital Epidemiology.

Mechanical complications of central venous catheters in children: A cohort study

David J Greencorn, J. Langley, K. Kulkarni, 2021, Infection Control & Hospital Epidemiology.

Variation in risk for nosocomial chickenpox after inadvertent exposure.

J. Langley, M. Hanakowski, 2000, The Journal of hospital infection.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–16

M. Mulvey, J. Langley, G. Taylor, 2018, The Journal of antimicrobial chemotherapy.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014

M. Mulvey, J. Langley, D. Gravel, 2016, Antimicrobial Agents and Chemotherapy.

Routine surveillance for bloodstream infections in a pediatric hematopoietic stem cell transplant cohort: Do patients benefit?

J. Langley, C. Fernandez, H. Rigby, 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Study of Cerebrospinal Fluid Shunt–Associated Infections in the First Year Following Placement, by the Canadian Nosocomial Infection Surveillance Program

J. Langley, D. Gravel, A. Matlow, 2009, Infection Control & Hospital Epidemiology.

Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.

J. Langley, L. Dodds, P. Andreou, 2019, The Pediatric infectious disease journal.

Study of interobserver reliability in clinical assessment of RSV lower respiratory illness: A pediatric investigators collaborative network for infections in Canada (PICNIC) study

J. Langley, D. Stephens, Joan L. Robinson, 1996, Pediatric pulmonology.

Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

J. Langley, S. Halperin, D. Macdougall, 2016, Vaccine.

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

J. Langley, S. Halperin, F. Boucher, 2004, Pediatrics.

A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection

J. Langley, B. Eastwood, S. Halperin, 1999, Pediatrics.

Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.

J. Langley, B. Eastwood, S. Halperin, 1997, Pediatrics.

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

K. Reisinger, J. Langley, S. Halperin, 2013, The Journal of infectious diseases.

Birth by Caesarean section and otitis media in childhood: a retrospective cohort study

J. Langley, J. Ashley-Martin, S. Kuhle, 2020, Scientific Reports.

The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design?

J. Langley, N. Dawe, M. E. Francis, 2020, Vaccines.

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial

O. Vanderkooi, J. Langley, L. Fries, 2012, Journal of the Pediatric Infectious Diseases Society.

Influenza-attributable deaths, Canada 1990–1999

D. Schanzer, J. Langley, T. Tam, 2007, Epidemiology and Infection.

Adolescent immunization – Protecting youth and preparing them for a healthy future

J. Langley, 2015, International journal of pediatrics & adolescent medicine.

Estimating Respiratory Syncytial Virus-associated Hospitalization in the First Year of Life Among Infants Born at 32–35 Weeks of Gestation

J. Langley, L. Dodds, P. Andreou, 2016, The Pediatric infectious disease journal.

Meeting Report: Harmonization of RSV therapeutics – from design to performance

O. Ramilo, A. Mejias, N. Papadopoulos, 2016, Journal of Global Health.

Meeting Report Meeting`report: `harmonizationòf`rsv`therapeutics`–`from`design`tò Performance , in Collaboration with Respiratory Syncytial Virus Network (resvinet)

O. Ramilo, A. Mejias, N. Papadopoulos, 2022 .

Pediatric Investigators Collaborative Network on Infections in Canada Study of Respiratory Syncytial Virus–associated Deaths in Pediatric Patients in Canada, 2003–2013

K. Leifso, J. Langley, J. Papenburg, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

J. Langley, P. Cahn, Wei Chen, 2021, The Lancet.

Acute febrile illness and a splenic mass in a 15-year-old West African immigrant.

J. Langley, J. Ahmed, T. Mailman, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial

J. Langley, Ping Li, S. Halperin, 2014, Journal of the Pediatric Infectious Diseases Society.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

O. Vanderkooi, S. Kuhn, J. Langley, 2012, Vaccine.

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

J. Langley, S. Halperin, S. Mcneil, 2006, Vaccine.

Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada

M. Loeb, J. Langley, M. Muller, 2018, Influenza and other respiratory viruses.

A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.

J. Langley, S. Halperin, A. Taddio, 2012, Vaccine.

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults.

J. Langley, S. Halperin, W. Heyward, 2012, Vaccine.

Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season

S. Trottier, M. Loeb, B. Light, 2016 .

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.

E. Wang, J. Langley, N. MacDonald, 1996, The Journal of pediatrics.

Evaluation of a tuberculosis screening program at a children's hospital.

J. Langley, S. Halperin, 1992, American journal of infection control.

Elevated Inflammatory Mediators in Adults with Oculorespiratory Syndrome following Influenza Immunization: a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study

J. Langley, S. Halperin, J. Bettinger, 2013, Clinical and Vaccine Immunology.

, Network Study Health Research Influenza Research Agency of Canada / Canadian Institutes of Influenza Immunization : a Public Health with Oculorespiratory Syndrome following Elevated Inflammatory Mediators in Adults

J. Langley, S. Halperin, M. Al-Dabbagh, 2013 .

Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections.

H. Davies, E. Wang, J. Langley, 2000, Journal of clinical epidemiology.

Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)

S. Trottier, M. Loeb, B. Light, 2016 .

The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.

Steven M. Smith, J. Slaunwhite, J. Langley, 2016, Vaccine.

Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.

J. Langley, S. Halperin, K. Top, 2017, Vaccine.

Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.

J. Langley, S. Halperin, K. Top, 2016, Vaccine.

Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study.

E. Wang, J. Langley, N. MacDonald, 1997, The Journal of pediatrics.

The palivizumab patchwork: Variation in guidelines for Respiratory Syncytial Virus prevention across Canadian provinces and territories.

J. Langley, M. Jalink, 2020, Paediatrics & child health.

Perspectivas epidemiológicas sanitarias en relación con las October 2006 Recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis

J. Langley, W. Huskins, J. Siegel, 2007 .

Chapter 97 Health Care–Associated Infection in the Pediatric Intensive Care Unit Epidemiology and Control—Keeping Patients Safe

J. Langley, P. Skippen, Tracie L. Northway, 2011, Pediatric Critical Care.

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.

M. Ison, J. Langley, L. Cámpora, 2023, The New England journal of medicine.

Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada

A. Galvani, S. Moghadas, J. Langley, 2021, Preventive Medicine.

Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada

S. Moghadas, J. Langley, T. Vilches, 2020, Vaccine.

Routine saliva testing for the identification of silent coronavirus disease 2019 (COVID-19) in healthcare workers

A. Galvani, S. Moghadas, J. Langley, 2021, Infection Control & Hospital Epidemiology.

Routine saliva testing for the identification of silent COVID-19 infections in healthcare workers

A. Galvani, S. Moghadas, J. Langley, 2020, medRxiv.

Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls

L. Kovacs, A. Synnes, R. Sauve, 2014, BMC Infectious Diseases.

J. Langley, S. Halperin, B. Ward, 2012 .

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis

A. M. Kazi, S. Omer, J. Langley, 2021, Vaccine.

Strategies for successful rapid trials of influenza vaccine

J. Langley, S. Halperin, D. Scheifele, 2011, Clinical trials.

Cerebrospinal fluid shunt–associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals

J. Langley, J. Conly, J. Comeau, 2022, Infection Control & Hospital Epidemiology.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.

J. Langley, S. Halperin, D. Macdougall, 2015, Vaccine.

The Pediatric Investigators Collaborative Network on Infections in Canada Study of Predictors of Hospitalization for Respiratory Syncytial Virus Infection for Infants Born at 33 Through 35 Completed Weeks of Gestation

Ian Mitchell, Hervé Walti, Brian Simmons, 2004, The Pediatric infectious disease journal.

Immunization: a global challenge for the 21st Century

J. Langley, M. Naus, 2011, Expert review of vaccines.

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Adrian M. Garcia, S. Madhi, J. Langley, 2023, The Journal of infectious diseases.

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age

Andrea A. Berry, N. Chiu, J. Langley, 2022, The Journal of infectious diseases.

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.

J. Langley, Ping Li, L. Fries, 2010, The Journal of infectious diseases.

Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals

Dena L. Schanzer, D. Schanzer, J. Langley, 2008, Influenza and other respiratory viruses.

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

S. Madhi, S. Stoszek, J. Langley, 2023, Journal of the Pediatric Infectious Diseases Society.

Encephalitis in the summer: a case of snowshoe hare (California serogroup) virus infection in Nova Scotia.

M. Drebot, H. Artsob, J. Langley, 2007, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

D. Vaughn, J. Langley, Ping Li, 2011, The Journal of infectious diseases.

Nosocomial Cerebrospinal fluid (CSF) Shunt Infection Rates (IR) May Be Higher in Canadian Children: Canadian Nosocomial Infection Surveillance Program (CNISP)

J. Langley, 2005 .

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults.

J. Langley, S. Halperin, A. Kimura, 2007, Vaccine.

Development and Validation of a Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalization in Premature Infants Born at 33 through 35 Completed Weeks of Gestation

Ian Mitchell, J. Sampalis, J. Langley, 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

Defining pneumonia in critically ill infants and children

J. Langley, J. Bradley, 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

From soap and water, to waterless agents: Update on hand hygiene in healthcare settings.

H. Davies, J. Langley, S. Halperin, 2002, Paediatrics & child health.

Implementation of a universal rotavirus vaccination program: comparison of two delivery systems

J. Langley, C. Sanford, Mitchell Zelman, 2014, BMC Public Health.

Canadian vaccine research networks: Vaccine safety resources for Canada.

J. Langley, S. Deeks, N. Crowcroft, 2015, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Commentary: Waterless hand hygiene--if there's a will, there's a way.

J. Langley, 2002, The Pediatric infectious disease journal.

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

J. Langley, S. Halperin, A. McGeer, 2015, Vaccine.

Modelling the Impact of Influenza in Canada: A Baseline for Pandemic Planning

D. Schanzer, J. Langley, T. Tam, 2006 .

Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age: Safety and Immunogenicity

D. Vaughn, A. Madan, J. Langley, 2012, The Pediatric infectious disease journal.

The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine.

J. Langley, T. Vesikari, F. Diaz-Mitoma, 2023, Vaccine.

Against vaccine assay secrecy

J. Langley, S. Halperin, M. Herder, 2015, Human vaccines & immunotherapeutics.

Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018

J. Langley, J. Conly, Bonita E. Lee, 2023, Antimicrobial Resistance & Infection Control.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

S. Trottier, M. Loeb, A. Chit, 2019, Chest.

Prevention of influenza in the general population

J. Langley, M. Faughnan, 2004, Canadian Medical Association Journal.

A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial.

J. Langley, S. Halperin, Bruce Smith, 2003, Vaccine.

Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study.

J. Langley, B. Millson, S. Mac, 2023, Vaccine.

Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease: A Canadian Immunisation Research Network (CIRN) Study

A. Galvani, S. Moghadas, J. Langley, 2023, medRxiv.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults

S. Trottier, M. Loeb, A. Chit, 2019, Journal of medical microbiology.

Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada.

D. Schanzer, J. Langley, T. Tam, 2008, Vaccine.

Statement on Bacille Calmette Guérin (BCG) vaccine.

J. Langley, S. Deeks, E. Ellis, 2004, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2011, Vaccine.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2013, Vaccine.

In Memoriam, Bernard Duval (1949 – 2008)

J. Langley, G. De Serres, 2009, Human vaccines.

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness

S. Trottier, M. Loeb, J. Langley, 2023, Open forum infectious diseases.

Lyme disease in children: Data from the Canadian Paediatric Surveillance Program.

J. Langley, L. R. Lindsay, N. Ogden, 2019, Ticks and tick-borne diseases.

Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial

R. Geskus, J. Langley, P. Bejon, 2018, Wellcome open research.

Commentary on ‘Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts’, with response from review author

J. Langley, 2006 .

Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010.

H. Schünemann, J. Langley, T. Mertens, 2012, Vaccine.

Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015–2020

J. Langley, L. Pelude, G. Evans, 2023, Journal of the Pediatric Infectious Diseases Society.

An Incremental Economic Evaluation of Targeted and Universal Influenza Vaccination in Pregnant Women

J. Langley, N. MacDonald, S. Mcneil, 2011 .

Immune Responses to Pertussis Vaccines Concurrently Administered with Viral Vaccines

J. Langley, B. Eastwood, S. Halperin, 1995, Annals of the New York Academy of Sciences.

Dexamethasone therapy for bacterial meningitis: Better never than late?

E. Wang, J. Langley, J. Langley, 1994, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Vaccine Prevention of Respiratory Syncytial Virus Infection in Older Adults: The Work Continues.

J. Langley, 2017, The Journal of infectious diseases.

Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006–2007 season

J. Langley, 2006, Canadian Medical Association Journal.

LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

M. Ison, J. Langley, F. Martinón-Torres, 2022, Open Forum Infectious Diseases.

Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program.

J. Langley, A. Warren, Jeff Scott, 2007, The Canadian journal of cardiology.

Prospects for defined epitope vaccines for respiratory syncytial virus.

J. Langley, Robert Anderson, Y. Huang, 2010, Future microbiology.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

J. Singer, Dianne Miller, J. Langley, 2013, Journal of the American Medical Association (JAMA).

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, A. Pollard, 2006 .

Rapid disappearance of influenza following the implementation of COVID-19 mitigation measures in Hamilton, Ontario

S. Moghadas, J. Langley, M. Smieja, 2020, medRxiv.

Epidemiologic study of 4684 hospital‐acquired infections in pediatric patients

R Milner, J. Langley, J. Langley, 1989, The Pediatric infectious disease journal.